Neurol. praxi. 2019;20(6):455-459
Multiple sclerosis and pregnancy – first line treatment and escalation therapy
- Neurologická klinika LF UK a FN v Hradci Králové
Multiple sclerosis (MS) is a chronic autoimmune neurodegenerative disease that affects predominantly young females of childbearing age. Historically, women with MS were discouraged from having children as pregnancy was thought to negatively affect the disease course. However, over the past few decades, studies have shown that the opposite is true. Thanks to scientific research and modern therapeutic approaches many women remain clinically and radiologically stable and they can give birth to healthy babies. Unfortunately, there is limited information regarding the safety of disease-modifying drugs (DMD) during pregnancy. The paper deals with the possible risks of individual DMD used for MS in early pregnancy.
Keywords: multiple sclerosis, pregnancy, treatment
Published: December 1, 2019 Show citation
